Screening of anti-dengue activity in methanolic extracts of medicinal plants

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Tang, Leon I C ^a   Ling, Anna P K ^a   Koh, Rhun Y ^a   Chye, Soi M ^a   Voon, Kenny G L ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ANTIVIRUS AGENT; CITRUS LIMON EXTRACT; CYMBOPOGON CITRATUS EXTRACT; FLAVONOID; METHANOL; MOMORDICA CHARANTIA EXTRACT; OCIMUM SANCTUM EXTRACT; PELARGONIUM CITROSUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANDROGRAPHIS PANICULATA; ANTIVIRAL ACTIVITY; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYMBOPOGON CITRATUS; DENGUE; DRUG SCREENING; IN VITRO STUDY; LEMON; MEDICINAL PLANT; MOMORDICA CHARANTIA; NONHUMAN; OCIMUM TENUIFLORUM; PELARGONIUM CITROSUM; VERO CELL; ANDROGRAPHIS; ANIMAL; CELL LINE; CHEMISTRY; CITRUS; CYMBOPOGON; HAPLORHINI; MICROBIOLOGICAL EXAMINATION; MOMORDICA; OCIMUM; PELARGONIUM; PHYTOTHERAPY;

ANDROGRAPHIS; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CITRUS; CYMBOPOGON; DENGUE; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; HAPLORHINI; MICROBIAL SENSITIVITY TESTS; MOMORDICA; OCIMUM; PELARGONIUM; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84855748516     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-3     Document Type: Article

References (41)

1. Halstead SB. Dengue virus - Mosquito interactions. Annu Rev Entomol 2008, 53:273-291. 10.1146/annurev.ento.53.103106.093326, 17803458.
2. Guzman MG, Kouri G. Dengue diagnosis, advances and challenges. Int J Infect Dis 2004, 8:69-80. 10.1016/j.ijid.2003.03.003, 14732325.
3. Gibbons RV. Dengue conundrums. Int J Antimicrob Agents 2010, 365:S36-S39.
4. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11:480-96. 88892, 9665979.
5. Murrell S, Wu SC, Butler M. Review of dengue virus and the development of a vaccine. Biotechnol Adv 2011, 29:239-247. 10.1016/j.biotechadv.2010.11.008, 21146601.
6. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997, 176:322-330. 10.1086/514048, 9237696.
7. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol 2005, 32:811-816. 10.1111/j.1440-1681.2005.04270.x, 16173941.
8. Pourmorad F, Hosseinimehr SJ, Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. Afr J Biotechnol 2006, 5:1142-1145.
9. Liu HS, Tzeng HC, Chen CC. Monitoring the cDNA synthesis of dengue-2 virus by RT PCR. J Virol Methods 1995, 51:55-59. 10.1016/0166-0934(94)00111-S, 7730437.
10. Gray J. From assays for virus infection. Virus culture: a practical approach 1999, 81-84. New York: Oxford University Press, Cann AJ.
11. Kudi AC, Myint MS. Antiviral activity of some Nigerian medicinal plant extracts. J Ethnopharmocol 1999, 68:289-294.
12. Sanchez I, Gomez-Garibay F, Taboada J, Ruiz BH. Antiviral effect of flavonoids on the dengue virus. Phytother Res 2000, 14:89-92. 10.1002/(SICI)1099-1573(200003)14:2<89::AID-PTR569>3.0.CO;2-C, 10685103.
13. Ozcelik B, Kartal M, Orhan I. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm Biol 2011, 49:396-402. 10.3109/13880209.2010.519390, 21391841.
14. Devi PU, Bisht KS, Vinitha M. A comparative study of radioprotection by Ocimum flavonoids and synthetic aminothiol protectors in the mouse. Br J Radiol 1998, 71:782-784.
15. Anandjiwala S, Kalola J, Rajani M. Quantification of eugenol, luteolin, ursolic acid, and oleanolic acid in black (Krishna Tulasi) and green (Sri Tulasi) varieties of Ocimum sanctum Linn. using high-performance thin-layer chromatography. J AOAC Int 2006, 89:1467-1474.
16. Uma DP, Ganasoundari A, Rao BS, Srinivasan KK. In vivo radioprotection by ocimum flavonoids: survival of mice. Radiat Res 1999, 151:74-78. 10.2307/3579750, 9973087.
17. Hilgard PSR. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocyte. Hepatology 2000, 32:1069-1077. 10.1053/jhep.2000.18713, 11050058.
18. Theoharides Luteolin as a Therapeutic Option for Multiple Sclerosis. J Neuroinflammation 2009, 6:29. 10.1186/1742-2094-6-29, 2768692, 19825165, Theoharides.
19. Mala Agarwal RK. Studies on flavonoid production using in vitro cultures of Momordica charantia. Indian J Biotechnol 2007, 6:277-279.
20. Lin JY, Tang CY. Determination of total phenolic and flavonoid contents in selected fruits and vegetables, as well as their stimulatory effects on mouse splenocyte proliferation. Food Chem 2007, 101:140-147.
21. Kaul TN, Middleton E, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol 1985, 15:71-79. 10.1002/jmv.1890150110, 2981979.
22. Chao WW, Lin BF. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med 2010, 5:17. 10.1186/1749-8546-5-17, 2881933, 20465823.
23. Fuster MD. Citrus Flavonoids. Distribution, modulation by phytorregulators and their possible physiological function. PhD. University of Murcia. Spain 1997,
24. Wu TS. Flavonoids from root bark of Citrus sinensis and C. nobilis. Phytochem 1989, 28:3558-3560.
25. Negrelle RRB, Gomes EC. Cymbopogon citratus (DC) Stapf: Chemical composition and biological activities. Rev Bras Pl Med 2007, 9:80-92.
26. De Matouschek. Phytochemical studies on non-volatile constituents of Cymbopogon citratus (DC.) Stapf grown in Morocco. Pharm Acta Helv 1991, 66:242-245.
27. Meyers M. Pelargoniums: An Herb Society of America Guide. The Herb Society of America 2006,
28. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem 2002, 13:572-584. 10.1016/S0955-2863(02)00208-5, 12550068.
29. Boyle SP, Dobson VL, Duthie SJ, Kyle JA, Collins AR. Absorption and DNA protective effects of flavonoid glycosides from an onion meal. Eur J Nutr 2000, 39:213-223. 10.1007/s003940070014, 11131368.
30. Oteiza PIEA, Verstraeten SV, Keen CL, Fraga CG. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface?. Clin Dev Immunol 2005, 12:19-25. 10.1080/10446670410001722168, 2270717, 15712595.
31. Chang RS, Chen GQ, Pan QC, Zhao ZL, Smith KM. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 1991, 197:59-66.
32. Ono K, Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J Biochem 1990, 108:609-613.
33. Kumar RA, Sridevi K, Kumar NV, Nanduri S, Rajagopal S. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004, 92:291-295. 10.1016/j.jep.2004.03.004, 15138014.
34. Reddy VL, Reddy SM, Ravikanth V, Krishnaiah P, Goud TV, Rao TP, Ram TS, Gonnade RG, Bhadbhade M, Venkateswarlu Y. A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity. Nat Prod Res 2005, 19:223-230. 10.1080/14786410410001709197, 15702635.
35. Mwambete KD. The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: a Tanzania medicinal plant. Afr Health Sci 2009, 9:34-39. 2932517, 20842240.
36. Grover KY, Yadav SP. Pharmacologicla actions and potential uses if Momordica charantia: a review. J Ethnopharmacol 2004, 93:123-132. 10.1016/j.jep.2004.03.035, 15182917.
37. Hayat Sholihin SA, Musthapa I, Qowiyah A. Kajian efek antihiperglikemia (antidiabet) fraksi dan komponen aktif buah paria (Momordica charantia Linn) serta penentuan kadar komponen aktif dengan metode HPLC. , http://penelitian.lppm.upi.edu/detil/1168/KAJIAN-EFEK-HIPOGLIKEMIA-(ANTIDIABET)-FRAKSI-DAN-KOMPONEN-AKTIF-BUAH-PARIA-(MOMORDICA-CHARANTIA-LINN.)-SERTA-PENENTUAN-KADAR-KOMPONEN-AKTIF-DENGAN-METODE-HPLC
38. Schnitzler P, Schneider S, Stintzing FC, Carle R, Reichling J. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus. Phytomedicine 2008, 15:1108-1116. 10.1016/j.phymed.2008.06.009, 18691858.
39. Modis Y, Ogata S, Clements D, Harrison SC. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427:313-319. 10.1038/nature02165, 14737159.
40. Wang L, Chen RF, Liu JW, Lee IK, Lee CP, Kuo HC, Huang SK, Yang KD. DC-SIGN (CD209) Promoter -336 A/G polymorphism is associated with dengue hemorrhagic fever and correlated to DC-SIGN expression and immune augmentation. PLoS Negl Trop Dis 2011, 5:934.
41. Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, William KL, Harris E, Fernandez-Sesma A, Schindler C, Garcia-Sastre A. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe 2010, 8:410-421. 10.1016/j.chom.2010.10.007, 21075352.